Hypha Labs Statistics
Total Valuation
Hypha Labs has a market cap or net worth of 5.43 million. The enterprise value is 7.37 million.
| Market Cap | 5.43M |
| Enterprise Value | 7.37M |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hypha Labs has 155.52 million shares outstanding. The number of shares has increased by 33.35% in one year.
| Current Share Class | 155.52M |
| Shares Outstanding | 155.52M |
| Shares Change (YoY) | +33.35% |
| Shares Change (QoQ) | +8.16% |
| Owned by Insiders (%) | 21.43% |
| Owned by Institutions (%) | n/a |
| Float | 122.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.38 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.85 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.99 |
| Interest Coverage | -27.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -407.44% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 139.95% |
| Weighted Average Cost of Capital (WACC) | 8.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -620,380 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.86% in the last 52 weeks. The beta is 1.00, so Hypha Labs's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +36.86% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 45.27 |
| Average Volume (20 Days) | 231,487 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.94M |
| Pretax Income | -3.10M |
| Net Income | -3.10M |
| EBITDA | -2.93M |
| EBIT | -2.94M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 38,118 in cash and 1.65 million in debt, with a net cash position of -1.61 million or -0.01 per share.
| Cash & Cash Equivalents | 38,118 |
| Total Debt | 1.65M |
| Net Cash | -1.61M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -2.10M |
| Book Value Per Share | -0.02 |
| Working Capital | -2.19M |
Cash Flow
In the last 12 months, operating cash flow was -379,975 and capital expenditures -32,966, giving a free cash flow of -412,941.
| Operating Cash Flow | -379,975 |
| Capital Expenditures | -32,966 |
| Free Cash Flow | -412,941 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Hypha Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.35% |
| Shareholder Yield | -33.35% |
| Earnings Yield | -57.15% |
| FCF Yield | -7.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 27, 2015. It was a reverse split with a ratio of 0.1.
| Last Split Date | May 27, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |